First official advice on GLP-1 medications for treating obesity is published.
WHO Releases Guidance on GLP-1 Drugs for Obesity Treatment The World Health Organization (WHO) has published new guidelines regarding the use of GLP-1 drugs for managing obesity. GLP-1 medications are designed to imitate the effects of the natural hormone glucagon-like peptide 1 and are mainly used in treating type 2 diabetes and aiding in weight […]
Managing holiday meals while using GLP-1 weight-loss medications
Impact of GLP-1 Weight Loss Medications on Social Interactions GLP-1 medications can aid in weight loss and support blood sugar control, but they also have the potential to alter social interactions significantly. As the holiday season draws near, those taking obesity medications may struggle with family meals or larger gatherings. This is largely due to […]
GLP-1 medications might allow colon cancer patients to have a longer life, research suggests
Study Links GLP-1 Drugs to Longer Lives for Colon Cancer Patients A recent study indicates that colon cancer patients could experience longer lifespans if they use GLP-1 medications, including Ozempic and Wegovy. Researchers from the University of California, San Diego examined over 6,800 patients who were prescribed these common diabetes and weight-loss drugs. The results […]
Data shows GLP-1 usage is greatest in states with the highest obesity rates.
The utilization of GLP-1 medications like Ozempic and Munjaro may see a significant rise due to a recent agreement in which former President Donald Trump committed to reducing the prices of these sought-after weight-loss drugs. Interestingly, adoption of these medications is already unevenly distributed across the United States, with some states experiencing a more pronounced […]
Brooks Nader acknowledges reliance on GLP-1 drugs, describes weight-loss medications as ‘a support’
Brooks Nader Addresses Weight Loss Drug Addiction Model Brooks Nader recently opened up about her ongoing struggle with addiction to weight loss drugs, despite her sisters’ intervention, which revealed a basket full of needles in her possession. During an episode of her reality show, “Love Thy Nader,” viewers saw Nader’s sisters confront her after finding […]
GLP-1 medications such as Ozempic and Wegovy could lessen the effects of alcohol, research indicates.
New Study Links Weight Loss Drugs to Alcohol Consumption A widely-used medication known for helping with weight loss and blood sugar control might also play a role in how individuals discuss alcohol, according to a recent study. Researchers at Virginia Tech’s Fralin Biomedical Research Institute looked into the effects of GLP-1 receptor agonists on a […]
Ozempic and other GLP-1 medications might affect the outcomes of medical scans.
GLP-1 Weight Loss Drug Under Development Recent research has revealed unexpected side effects linked to GLP-1 agonists like Ozempic, Wegovy, Mounjaro, and Zepbound. These drugs, commonly prescribed for diabetes and obesity, may disrupt medical imaging procedures, including PET and CT scans. The Cleveland Clinic points out that CT scans are essential for providing detailed images […]
GLP-1 medications might save the government billions — Congress needs to consider this.
The U.S. is grappling with a hefty public health and economic issue: obesity. Over 40% of American adults are classified as obese, which imposes a significant strain on the healthcare system—estimates suggest costs of around $173 billion each year. And honestly, that figure might just scratch the surface. Beyond direct medical expenses, obesity impacts workforce […]
Emerging ‘uncommon’ side effect of GLP-1 medications such as Ozempic increasingly reported
The side effects of GLP-1 weight loss medications can be quite varied, ranging from surprising bodily changes to, well, some pretty odd issues. Recent findings suggest that these widely used drugs might be altering crucial medical imaging scans, which can hinder doctors from identifying serious health problems, potentially even life-threatening ones. This interference could result […]
Americans are relying on unregulated sellers for GLP-1 weight-loss medications.
Concerns Rise Over Unregulated GLP-1 Drug Sales As interest in GLP-1 medications surges, particularly for weight loss and diabetes management, many Americans are opting for unregulated sellers instead of traditional pharmacies. This shift often stems from high costs, insurance issues, and consistent shortages. The FDA has issued warnings regarding the “gray market” for GLP-1 drugs, […]